Palatin Technologies
PTN
#9833
Rank
NZ$79.89 M
Marketcap
NZ$46.92
Share price
10.46%
Change (1 day)
3,048.47%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -NZ$28.79 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$46.39 Million, an increase over its 2023 earnings that were of -NZ$55.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$28.79 Million-37.96%
2024 -NZ$46.39 Million-16.9%
2023 -NZ$55.83 Million5.99%
2022 -NZ$52.67 Million-13.7%
2021 -NZ$61.03 Million33.25%
2020 -NZ$45.8 Million-172.11%
2019 NZ$63.51 M2352.33%
2018 NZ$2.58 M-94.13%
2017 NZ$44.13 M-154.92%
2016 -NZ$80.36 Million3.67%
2015 -NZ$77.51 Million878%
2014 -NZ$7.93 Million-72.64%
2013 -NZ$28.97 Million-33.11%
2012 -NZ$43.31 Million77.71%
2011 -NZ$24.37 Million
2003 -NZ$41.27 Million29.93%
2002 -NZ$31.76 Million36.18%
2001 -NZ$23.32 Million
1999 -NZ$19.36 Million6.04%
1998 -NZ$18.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-NZ$20.34 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$50.78 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.00 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$87.04 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.78 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$95.66 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.54 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK